Quidel | QDEL - Pre Tax Profit


Quidel reported $-79.5M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Agilent USD 408M 44M Mar/2026
Becton, Dickinson and Co. USD 39M 354M Mar/2026
Bruker USD 117M 95.1M Jun/2026
Cerus USD -20.76M 17.9M Dec/2024
Charles River Laboratories USD -29.94M 264.16M Mar/2026
Danaher USD 1.08B 157M Jun/2026
Haemonetics USD 47.57M 75.97M Jun/2026
Illumina USD 260M 103M Jun/2026
IQVIA Holdings USD 301M 5.92B Jun/2026
Merit Medical Systems USD 53.55M 2.49M Mar/2026
Mettler Toledo International USD 209.66M 119.42M Mar/2026
Myriad Genetics USD 4.6M 3.4M Dec/2025
Neogen USD -12.1M 8.2M Mar/2026
OraSure Technologies USD -18.43M 5.14M Dec/2025
Pacific Biosciences Of California USD -40.17M 2.55M Dec/2025
Quidel USD -79.5M 32.9M Mar/2026
Revvity USD 187.24M 137.25M Jun/2026
STAAR Surgical USD 8.22M 28.87M Mar/2026
Thermo Fisher Scientific USD 1.73B 389M Mar/2026
Waters USD 356M 444M Jun/2026